BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND EXT1, ttv, 2131, ENSG00000182197, EXT, Q16394 AND Treatment
17 results:

  • 1. How to handle brain tumors after esophagectomy with curative intent: A single center 20-year experience.
    Vanstraelen S; Depypere L; Moons J; Mandeville Y; Van Veer H; Lerut T; Coosemans W; Nafteux P
    Eur J Surg Oncol; 2023 Sep; 49(9):106916. PubMed ID: 37120317
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Does Esophagectomy Provide a Survival Advantage to Patients Aged 80 Years or Older? Analyzing 5066 Patients in the National Database of Hospital-based cancer Registries in Japan.
    Motoyama S; Maeda E; Iijima K; Sato Y; Koizumi S; Wakita A; Nagaki Y; Fujita H; Yoneya T; Imai K; Terata K; Minamiya Y; Higashi T
    Ann Surg; 2022 Jul; 276(1):e16-e23. PubMed ID: 33630469
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. external beam radiotherapy with or without californium-252 neutron brachytherapy for treatment of recurrence after definitive chemoradiotherapy.
    Wu WA; Yang YP; Liang J; Zhao J; Wang JS; Zhang J
    Sci Rep; 2020 Dec; 10(1):20902. PubMed ID: 33262384
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Impact of 18F-2-fluoro-2-deoxy-D-glucose PET/computerized tomography on the initial staging and changing the management intent in head and neck squamous cell carcinoma.
    Kandeel A; Saied M; Aldaly M; Darwish H; Alsayed Y
    Nucl Med Commun; 2021 Feb; 42(2):216-224. PubMed ID: 33165255
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic value of total tumor volume in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Liang SB; Teng JJ; Hu XF; Yang XL; Luo M; Fang XN; Liu DS; Chen Y; Fu LW
    BMC Cancer; 2017 Jul; 17(1):506. PubMed ID: 28754109
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The pattern of failure and predictors of locoregional control in lateralized buccogingival cancer after postoperative radiation therapy.
    Lai TY; Hu YW; Liu YM; Chen YW; Shiau CY; Chu PY; Tai SK; Lo WL; Wu CH; Wang LW
    J Chin Med Assoc; 2017 Sep; 80(9):569-574. PubMed ID: 28687157
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Meta-Analyses of Microarray Datasets Identifies ANO1 and FADD as Prognostic Markers of head and neck cancer.
    Reddy RB; Bhat AR; James BL; Govindan SV; Mathew R; Ravindra DR; Hedne N; Illiayaraja J; Kekatpure V; Khora SS; Hicks W; Tata P; Kuriakose MA; Suresh A
    PLoS One; 2016; 11(1):e0147409. PubMed ID: 26808319
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Efficacy and toxicity of (chemo)radiotherapy for primary subglottic cancer.
    Hata M; Taguchi T; Koike I; Nishimura G; Takahashi M; Komatsu M; Sano D; Odagiri K; Minagawa Y; Inoue T
    Strahlenther Onkol; 2013 Jan; 189(1):26-32. PubMed ID: 23161117
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic significance of radiologically determined neck node volume in head and neck cancer: a systematic review.
    Lodder WL; Pameijer FA; Rasch CR; van den Brekel MW; Balm AJ
    Oral Oncol; 2012 Apr; 48(4):298-302. PubMed ID: 22112442
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The calcium sensing receptor: from understanding parathyroid calcium homeostasis to bone metastases.
    Mihai R
    Ann R Coll Surg Engl; 2008 May; 90(4):271-7. PubMed ID: 18492387
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Differentiated thyroid carcinoma--how to improve the long-term results? Twenty-five-year outcomes of 850 patients].
    Melliere D; Hindie E; Becquemin JP; Desgranges P; Allaire E; Geachan E
    Bull Acad Natl Med; 2006 Jan; 190(1):89-106; discussion 106-9. PubMed ID: 16878448
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Changes in clinical presentation, management and outcome in 1348 patients with differentiated thyroid carcinoma: experience in a single institute in Hong Kong, 1960-2000.
    Chow SM; Law SC; Au SK; Mang O; Yau S; Yuen KT; Lau WH
    Clin Oncol (R Coll Radiol); 2003 Sep; 15(6):329-36. PubMed ID: 14524486
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy.
    Rudat V; Dietz A; Schramm O; Conradt C; Maier H; Flentje M; Wannenmacher M
    Radiother Oncol; 1999 Nov; 53(2):119-25. PubMed ID: 10665788
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome.
    Chua DT; Sham JS; Kwong DL; Tai KS; Wu PM; Lo M; Yung A; Choy D; Leong L
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):711-9. PubMed ID: 9336154
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Long-term follow-up of 92 patients with locally advanced follicular or papillary thyroid cancer after combined treatment.
    Glanzmann C; Lütolf UM
    Strahlenther Onkol; 1992 May; 168(5):260-9. PubMed ID: 1598660
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Computed tomographic density of metastatic lymph nodes as a treatment-related prognostic factor in advanced head and neck cancer.
    Munck JN; Cvitkovic E; Piekarski JD; Benhamou E; Recondo G; Bachouchi M; Tellez-Bernal E; Luboinski B; Eschwege F; Wibault P
    J Natl Cancer Inst; 1991 Apr; 83(8):569-75. PubMed ID: 1848639
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Local control of squamous cell carcinoma of the mobile tongue: an experience of different modalities.
    Kondo M; Hashimoto S; Dokiya T; Inuyama Y; Murakami Y; Nagai T; Asanami S; Fukutake K
    Int J Radiat Oncol Biol Phys; 1986 May; 12(5):755-60. PubMed ID: 3710860
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.